Acucela Inc.

Acucela Inc.

Biotechnology Research 818 Stewart Street 25 employees
Employees
25
Contacts
2
Emails
2
Phones
2

Acucela Inc. Overview

Headquarters
818 Stewart Street
Phone Number
Available in AeroLeads
Website
acucela.com
Industry
Biotechnology Research
Employees
25
Founded
2002
Funding
439.6K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Acucela Inc.

Acucela Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. Acucela’s development pipeline include drug candidates and therapeutics for the treatment of retinitis pigmentosa, proliferative diabetic retinopathy, diabetic macular edema, AMD, Stargardt disease, cataract and presbyopia. The company is also developing a monitoring device for neovascular retinal diseases, to be used directly by patients. http://www.acucela.com; http://www.kubotaholdings.co.jp/en/

Acucela Inc. Contact Details

People in AeroLeads
2
With contact data
2
Email contacts
2
100.0% coverage
Phone contacts
2
100.0% coverage

Acucela Inc. Org Chart

Sample employees and titles
Name Title Contact
Angie Muller Clinical Trial Manager at Acucela Inc.
Email Phone
Andriy Pashko Research Associate at Acucela Inc.
Email Phone

Employees by Management Level

Individual contributor 6 profiles
Associate / junior 4 profiles
Manager 3 profiles
Executive 1 profile
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 7 7 5
Healthcare 2 2 2
Legal 1 1 1
Executive 1 1 0

Compare Similar Companies to Acucela Inc.